Purpose

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Conditions

Eligibility

Eligible Ages
Between 3 Years and 25 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children Research Institute (BCRI) - Being diagnosed with HIV infection by the time of enrollment - At enrollment, 3 to < 26 years

Exclusion Criteria

  • Patient will be excluded from the study if any of the following are identified: - Patients under legal age and in the State's custody - Participant or legal guardian unable to sign Informed Consent forms - Participant unable to complete study visits

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross-Sectional

Arm Groups

ArmDescriptionAssigned Intervention
HIV positive participants with positive COVID-19 results Participants in this group will have a RT-PCR and Coronavirus Disease (COVID) -19 specific antibody testing at baseline, 1 month and 3 month visits.
HIV positive participants with negative COVID-19 results Participants in this group will have a RT-PCR and COVID-19 specific antibody testing at baseline only.

Recruiting Locations

More Details

NCT ID
NCT04514016
Status
Completed
Sponsor
University of Miami

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.